1. Home
  2. NKTX vs FONR Comparison

NKTX vs FONR Comparison

Compare NKTX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.09

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Logo Fonar Corporation

FONR

Fonar Corporation

HOLD

Current Price

$18.56

Market Cap

116.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
FONR
Founded
2015
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.8M
116.9M
IPO Year
2020
1987

Fundamental Metrics

Financial Performance
Metric
NKTX
FONR
Price
$2.09
$18.56
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$13.25
N/A
AVG Volume (30 Days)
708.2K
128.9K
Earning Date
11-10-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.08
Revenue
N/A
$105,434,318.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.10
Revenue Growth
N/A
3.36
52 Week Low
$1.31
$12.00
52 Week High
$2.74
$18.86

Technical Indicators

Market Signals
Indicator
NKTX
FONR
Relative Strength Index (RSI) 69.68 80.85
Support Level $1.79 $18.50
Resistance Level $2.22 $18.86
Average True Range (ATR) 0.08 0.15
MACD 0.04 0.31
Stochastic Oscillator 75.73 93.27

Price Performance

Historical Comparison
NKTX
FONR

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: